Macquarie Group LTD Takeda Pharmaceutical CO LTD Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Macquarie Group LTD holds 324 shares of TAK stock, worth $4,296. This represents 0.0% of its overall portfolio holdings.

Number of Shares

324

Previous 1,045,871 99.97%

Holding current value

$4,296

Previous $13.5 Million 99.97%

% of portfolio

0.0%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$13.0 - $15.08 $13.6 Million - $15.8 Million	-1,045,547 Reduced 99.97%	324 $4,000
Q2 2024 Aug 09, 2024	SELL	$12.6 - $13.67 $15.1 Million - $16.4 Million	-1,200,878 Reduced 53.45%	1,045,871 $13.5 Million
Q1 2024 May 14, 2024	SELL	$13.89 - $15.04 $2.77 Million - $3 Million	-199,193 Reduced 8.14%	2,246,749 $31.2 Million
Q4 2023 Feb 14, 2024	SELL	$13.36 - $15.43 $17.5 Million - $20.3 Million	-1,313,556 Reduced 34.94%	2,445,942 $34.9 Million
Q3 2023 Nov 14, 2023	SELL	$15.03 - $16.32 $1.07 Million - $1.16 Million	-71,257 Reduced 1.86%	3,759,498 $58.2 Million
Q2 2023 Aug 14, 2023	SELL	$15.57 - $17.11 $1.21 Million - $1.33 Million	-77,980 Reduced 2.0%	3,830,755 $60.2 Million
Q1 2023 May 15, 2023	BUY	$15.28 - $16.48 $1.11 Million - $1.2 Million	72,745 Added 1.9%	3,908,735 $64.4 Million
Q4 2022 Feb 21, 2023	SELL	$12.42 - $15.62 $1.96 Million - $2.47 Million	-158,054 Reduced 3.96%	3,835,990 $59.9 Million
Q3 2022 Nov 14, 2022	SELL	$12.8 - $28.65 $946,508 - $2.12 Million	-73,946 Reduced 1.82%	3,994,044 $51.8 Million
Q2 2022 Aug 15, 2022	SELL	$13.12 - $15.03 $2.01 Million - $2.31 Million	-153,391 Reduced 3.63%	4,067,990 $57.1 Million
Q1 2022 May 16, 2022	BUY	$13.54 - $15.35 $6.48 Million - $7.34 Million	478,256 Added 12.78%	4,221,381 $60.5 Million
Q4 2021 Feb 11, 2022	SELL	$13.17 - $16.4 $12.6 Million - $15.6 Million	-953,998 Reduced 20.31%	3,743,125 $51 Million
Q3 2021 Nov 12, 2021	SELL	$16.3 - $17.26 $710,500 - $752,346	-43,589 Reduced 0.92%	4,697,123 $76.9 Million
Q2 2021 Aug 13, 2021	BUY	$16.55 - $18.64 $7.27 Million - $8.19 Million	439,437 Added 10.22%	4,740,712 $79.8 Million
Q1 2021 May 14, 2021	BUY	$16.71 - $19.9 $609,915 - $726,350	36,500 Added 0.86%	4,301,275 $78.5 Million
Q4 2020 Feb 16, 2021	BUY	$15.39 - $18.97 $4.46 Million - $5.5 Million	290,037 Added 7.3%	4,264,775 $77.6 Million
Q3 2020 Nov 13, 2020	SELL	$17.1 - $19.19 $3.77 Million - $4.23 Million	-220,343 Reduced 5.25%	3,974,738 $70.9 Million
Q2 2020 Aug 11, 2020	SELL	$14.59 - $19.5 $12.3 Million - $16.5 Million	-844,716 Reduced 16.76%	4,195,081 $75.2 Million
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $906,478 - $1.41 Million	-69,622 Reduced 1.36%	5,039,797 $76.5 Million
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $3.23 Million - $3.98 Million	-191,217 Reduced 3.61%	5,109,419 $101 Million
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $3.32 Million - $3.7 Million	-205,467 Reduced 3.73%	5,300,636 $91.2 Million
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $12 Million - $14.9 Million	724,835 Added 15.16%	5,506,103 $97.5 Million
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $79.8 Million - $103 Million	4,781,268 New	4,781,268 $97.4 Million

Others Institutions Holding TAK

# of Institutions

339

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Takeda Pharmaceutical CO LTD Transaction History